KR100891720B1 - 4-carbamoylphenylacetic acid from Pseudomonas chlororapis O6 which induces resistance to plant diseases and uses thereof - Google Patents
4-carbamoylphenylacetic acid from Pseudomonas chlororapis O6 which induces resistance to plant diseases and uses thereof Download PDFInfo
- Publication number
- KR100891720B1 KR100891720B1 KR1020070093239A KR20070093239A KR100891720B1 KR 100891720 B1 KR100891720 B1 KR 100891720B1 KR 1020070093239 A KR1020070093239 A KR 1020070093239A KR 20070093239 A KR20070093239 A KR 20070093239A KR 100891720 B1 KR100891720 B1 KR 100891720B1
- Authority
- KR
- South Korea
- Prior art keywords
- pseudomonas
- resistance
- acid
- tobacco
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- ZGWAEKSJTSFZSS-UHFFFAOYSA-N 2-(4-carbamoylphenyl)acetic acid Chemical compound NC(=O)C1=CC=C(CC(O)=O)C=C1 ZGWAEKSJTSFZSS-UHFFFAOYSA-N 0.000 title claims abstract description 31
- 241000589516 Pseudomonas Species 0.000 title claims abstract description 31
- 201000010099 disease Diseases 0.000 title abstract description 39
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 39
- 230000001939 inductive effect Effects 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 14
- 230000001404 mediated effect Effects 0.000 claims abstract description 11
- 241000589615 Pseudomonas syringae Species 0.000 claims abstract description 9
- 230000006698 induction Effects 0.000 claims abstract description 6
- 241000208125 Nicotiana Species 0.000 claims description 35
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 35
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical group CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 239000001963 growth medium Substances 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 4
- 241001008516 Pseudomonas chlororaphis O6 Species 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 208000035240 Disease Resistance Diseases 0.000 abstract description 20
- 239000000126 substance Substances 0.000 abstract description 20
- 239000000411 inducer Substances 0.000 abstract description 13
- 241000589624 Pseudomonas amygdali pv. tabaci Species 0.000 abstract description 2
- 239000011021 lapis lazuli Substances 0.000 abstract description 2
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 46
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 230000000694 effects Effects 0.000 description 13
- 239000000463 material Substances 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 8
- 239000002207 metabolite Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000233866 Fungi Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 229960004889 salicylic acid Drugs 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 229930002875 chlorophyll Natural products 0.000 description 3
- 235000019804 chlorophyll Nutrition 0.000 description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- OQEBBZSWEGYTPG-UHFFFAOYSA-N 3-aminobutanoic acid Chemical compound CC(N)CC(O)=O OQEBBZSWEGYTPG-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000724252 Cucumber mosaic virus Species 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 241001002356 Valeriana edulis Species 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000002021 butanolic extract Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 244000000003 plant pathogen Species 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- SQSYNRCXIZHKAI-UHFFFAOYSA-N 2,6-dichloroisonicotinic acid Chemical compound OC(=O)C1=CC(Cl)=NC(Cl)=C1 SQSYNRCXIZHKAI-UHFFFAOYSA-N 0.000 description 1
- MIIIXQJBDGSIKL-UHFFFAOYSA-N 2-morpholin-4-ylethanesulfonic acid;hydrate Chemical compound O.OS(=O)(=O)CCN1CCOCC1 MIIIXQJBDGSIKL-UHFFFAOYSA-N 0.000 description 1
- -1 4-carbamoylphenyl Chemical group 0.000 description 1
- 239000005964 Acibenzolar-S-methyl Substances 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- UELITFHSCLAHKR-UHFFFAOYSA-N acibenzolar-S-methyl Chemical group CSC(=O)C1=CC=CC2=C1SN=N2 UELITFHSCLAHKR-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000000443 biocontrol Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical compound [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000004896 high resolution mass spectrometry Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012594 liquid chromatography nuclear magnetic resonance Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006273 synthetic pesticide Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/08—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
본 발명은 식물병, 특히 담배의 슈도모나스 시린개 pv. 타바시(Pseudomonas syringae pv. tabaci) 매개 들불병(wild fire)에 대한 저항성을 유도하는, 슈도모나스 클로로라피스 O6(Pseudomonas chlororaphis O6)로부터 유래된 4-카바모일페닐아세트산(4-carbamoylphenylacetic acid), 상기 물질을 함유하는 식물병 저항성 유도제, 및 상기 물질을 이용하는 식물병 저항성 유도방법에 관한 것이다.The present invention relates to plant diseases, particularly Pseudomonas syringae pv. The other Bridge (Pseudomonas syringae pv. Tabaci) mediated wildfire disease (wild fire) chloro, Pseudomonas inducing resistance to O6 lapis (Pseudomonas 4-carbamoylphenylacetic acid derived from chlororaphis O6), a plant disease resistance inducer containing the substance, and a plant disease resistance induction method using the substance.
Description
본 발명은 식물병에 대한 저항성을 유도하는 신규 물질 및 그의 용도에 관한 것으로서, 보다 상세하게는, 식물병, 특히 담배의 슈도모나스 시린개 pv. 타바시(Pseudomonas syringae pv. tabaci) 매개 들불병(wild fire)에 대한 저항성을 유도하는, 슈도모나스 클로로라피스 O6(Pseudomonas chlororaphis O6)로부터 유래된, 화학식 1의 4-카바모일페닐아세트산[(4-carbamoylphenyl)acetic acid], 상기 물질을 함유하는 식물병 저항성 유도제, 및 상기 물질을 이용하는 식물병 저항성 유도방법에 관한 것이다.The present invention relates to novel substances and their use for inducing resistance to plant diseases, and more particularly, to Pseudomonas syringae pv. 4-carbamoylphenylacetic acid [(4-carbamoylphenyl) derived from Pseudomonas chlororaphis O6, which induces resistance to Pseudomonas syringae pv.tabaci mediated wild fire. ) acetic acid], a plant disease resistance inducer containing the substance, and a plant disease resistance induction method using the substance.
식물은 생육전반에 걸쳐 병을 일으키는 다양한 미생물들의 공격에 노출되어 있다. 식물이 병에 걸리게 되면 생장 및 생육이 억제되고 여러 형태의 병징을 나타낸다. 결과적으로, 식물의 일부 또는 전체가 죽게 되는 결과를 초래하며 작물의 경우 생산성이 급격히 감소하게 된다. 화학합성 농약을 사용하지 않고 미생물학적으로 식물병을 예방 또는 치료하는 친환경적인 기술로는 항생물질을 생성하는 미생물을 이용하는 방법(문헌 [Folman, L.B. et al. (2004) Biol Control 31, 145-154]), 효소를 생성하는 미생물을 이용하는 방법(문헌 [Chae, D.H. et al. (2006) Biocontrol 51, 339-351]), 식물의 발육을 촉진시키는 방법(문헌 [Zdor, R. et al. (1992) Plant Soil 140, 99-107]) 등과 같이 다양하다. 또한, 식물병이 발생하기 전에 미리 페나진(phenazine)을 생성하는 미생물을 식물에 처리함으로써 식물로 하여금 병에 대한 저항성을 갖게 하여 병에 걸리지 않게 하는 예방법도 있다(문헌 [Pierson, L.S. et al. (1992) Mol Plant-Microbe Interact 5, 330-339]). 페나진 이외에도 아시벤졸라-S-메틸(acibenzolar-S-methyl)(문헌 [Kunz W. et al. (1997) J Pestic Sci 50, 275-282]), 2,6-디클로로이소니콘틴산(문헌 [Metraux J.P. et al. (1991) Mol Plant-Microbe Interact 1, 432-439]), 살리실산(문헌 [Sticher L. et al. (1997) Annu Rev Plant Pathol 35, 235-270]), 프로베나졸(probenazole)(문헌 [Watanabe T. (1997) J Pestic Sci 2, 394-404]), 베타-아미노부티르산(문헌 [Tosi et al. (1998) J Phytopathol 146, 259-280]) 등도 식물병에 대한 저항성을 유도하는 것으로 알려져 있다.Plants are exposed to the attack of various microorganisms that cause disease throughout their growth. When a plant becomes diseased, its growth and growth are inhibited and show several forms of disease. This results in the death of some or all of the plants and, in the case of crops, productivity is drastically reduced. As an environmentally friendly technique that prevents or treats plant diseases microbiologically without using chemical synthetic pesticides, a method using microorganisms that produce antibiotics (Folman, LB et al. (2004) Biol Control 31, 145-154 ]), Methods using microorganisms that produce enzymes (Chae, DH et al. (2006) Biocontrol 51, 339-351), methods of promoting plant development (Zdor, R. et al. ( 1992) Plant Soil 140, 99-107]. There is also a preventive method in which plants are treated with microorganisms that produce phenazine in advance before the plant disease occurs, thereby making the plant resistant to the disease and preventing the disease (Pierson, LS et al. (1992) Mol Plant-Microbe Interact 5, 330-339]. In addition to phenazine, acibenzolar-S-methyl (Kunz W. et al. (1997) J Pestic Sci 50, 275-282), 2,6-dichloroisonicotinic acid (document (Metraux JP et al. (1991) Mol Plant-Microbe Interact 1, 432-439), salicylic acid (Sticher L. et al. (1997) Annu Rev Plant Pathol 35, 235-270), probenazole (probenazole) (Watanabe T. (1997) J Pestic Sci 2, 394-404), beta-aminobutyric acid (Tosi et al. (1998) J Phytopathol 146, 259-280), and the like. It is known to induce resistance to.
본 발명자는 토양으로부터 식물 병원균에 대한 전신 저항성과 가뭄에 대한 내성을 유도하는 능력을 가지는 식물 근권 미생물인 슈도모나스 클로로라피스 O6 균주(수탁번호 KACC 91054)를 분리·동정해내고, 균주 자체와 상기 균주를 이용하여 식물 병원균, 특히 고추 세균성 시들음병균, 오이 갈반병균, 세균성 점무늬병균, 오이 모자이크 바이러스, 담배 무름병균, 담배 들불병균, 묘시들음병균, 토양 곰팡이에 대한 전신 저항성을 유도하는 방법에 대해 출원번호 제2003-62692호로 특허출원하여 등록번호 제521,744호로 특허를 받은 바 있다. 슈도모나스 클로로라피스 O6는 식물이 병에 대한 저항성을 갖게 하여 그 병을 예방하는 기능을 갖는 것으로 알려져 있으며(문헌 [Spencer, M., et al. (2003) Physiol Mol Plant Pathol 63, 27-34]), 페나진과 같은 기존의 식물병 저항성 유도물질 생성과는 무관하게 식물병 저항성을 유도하는 것으로 보고되어 있다(문헌 [Han, S.H., et al. (2006) Moi Plant-Microbe Interact 19, 924-930]). 그러나 지금까지 슈도모나스 클로로라피스 O6의 어떠한 대사물질이 담배 들불병 저항성을 유도하는 기능을 하는지에 대해서는 밝혀진 바가 없었다. 들불병은 담배 병해의 하나로서, 슈도모나스 시린개 pv. 타바시라고 하는 세균의 기생에 의해서 일어난다. 잎에 수침상(水浸狀)의 작고 짙은 황색의 반점이 생기고 후에 병반(病斑) 둘레에 뚜렷한 황색의 무리가 생긴다. 병반은 옆의 병반과 이어지면서 커져 결국 잎은 갈래갈래 찢어진다. 이 병은 특히 폭풍우가 지난 후에 마치 들불이 퍼지듯 급속히 번져서 큰 피해를 주므로 들불병이라고 불린다.The inventors isolated and identified Pseudomonas Chlorophyll O6 strain (Accession No. KACC 91054), a plant rhizome microorganism having the ability to induce systemic resistance and drought resistance to plant pathogens from soil, and isolated the strain itself and the strain. Application No. 3 for the method of inducing systemic resistance to plant pathogens, especially pepper bacterial wilt, cucumber streptococcus, bacterial spot pattern germ, cucumber mosaic virus, tobacco soft germ, tobacco wild germ, mysterious fungus and soil fungus The patent was filed in 2003-62692 and patented under the registration number 521,744. Pseudomonas chlorolapis O6 is known to have a function of preventing plants from making them resistant to disease (Spencer, M., et al. (2003) Physiol Mol Plant Pathol 63, 27-34). Has been reported to induce plant disease resistance irrespective of existing plant disease resistance inducers such as phenazine (Han, SH, et al. (2006) Moi Plant-Microbe Interact 19, 924-930). ). However, until now, no metabolites of Pseudomonas chlorolapis O6 function to induce tobacco wildfire resistance. Wildfire disease is one of the tobacco diseases, and Pseudomonas syringe pv. It is caused by a parasitic of a bacterium called Tabashi. A leaf has a small, dark yellow spot on the needle, and later a clear yellow cluster around the lesion. The lesion grows in conjunction with the adjacent lesion and eventually leaves the forks torn. The disease is called wildfire because it spreads rapidly and causes great damage, especially after a storm.
본 발명자들은 상기 슈도모나스 클로로라피스 O6의 어떤 대사물질이 들불병 저항성 유도에 관여하는지를 규명하기 위하여, 지속적인 연구를 수행하였다. 그 결과, 신규 물질인 4-카바모일페닐아세트산이 식물병 저항성을 유도하는 활성 물질임을 밝혀내고 상기 물질이 실제로 담배 들불병에 대한 저항성을 유도하는 활성을 나타냄을 생물학적으로 검증함으로써, 본 발명을 완성하기에 이르렀다.The present inventors conducted an ongoing study to determine which metabolites of Pseudomonas chlorolapis O6 are involved in inducing wildfire resistance. As a result, the present invention was completed by finding out that 4-carbamoylphenylacetic acid, a novel substance, is an active substance that induces plant disease resistance and biologically verifying that the substance actually exhibits activity that induces resistance to tobacco wildfire. It came to the following.
따라서 본 발명의 목적은 식물병, 특히 담배의 슈도모나스 시린개 pv. 타바시 매개 들불병에 대한 저항성을 유도하는, 슈도모나스 클로로라피스 O6로부터 유래된 신규 물질, 4-카바모일페닐아세트산을 제공하기 위한 것이다.It is therefore an object of the present invention to provide plant diseases, in particular Pseudomonas syringe pv. To provide a novel substance, 4-carbamoylphenylacetic acid, derived from Pseudomonas chlorolapis O6, which induces resistance to Tabashi mediated wildfire.
본 발명의 다른 목적은 상기 4-카바모일페닐아세트산을 함유하는, 식물병, 특히 담배의 슈도모나스 시린개 pv. 타바시 매개 들불병에 대한 저항성 유도제를 제공하기 위한 것이다.Another object of the present invention is to give Pseudomonas syringae pv. Of plant diseases, especially tobacco, containing said 4-carbamoylphenylacetic acid. To provide a resistance inducer to Tabashi mediated wildfire.
본 발명의 또 다른 목적은 상기 4-카바모일페닐아세트산을 이용하여, 식물병, 특히 담배의 슈도모나스 시린개 pv. 타바시 매개 들불병에 대한 저항성을 유도하는 방법을 제공하기 위한 것이다.Another object of the present invention is to use the 4-carbamoylphenylacetic acid, plant diseases, in particular Pseudomonas syringe pv. To provide a method for inducing resistance to Tabashi-mediated wildfire.
첫째, 본 발명은 화학식 1의 4-카바모일페닐아세트산에 관한 것이다.First, the present invention relates to 4-carbamoylphenylacetic acid of formula (1).
[화학식 1][Formula 1]
상기 물질은 식물병, 특히 담배의 슈도모나스 시린개 pv. 타바시 매개 들불병에 대한 저항성을 유도하는, 슈도모나스 클로로라피스 O6로부터 유래된 신규 물질이다.The material is a plant disease, in particular Pseudomonas syringae pv. It is a novel substance derived from Pseudomonas chlorolapis O6, which induces resistance to Tabashi mediated wildfire.
둘째, 본 발명은 유효성분으로서 4-카바모일페닐아세트산을 함유하는, 식물병에 대한 저항성 유도제에 관한 것이다. 상기 식물병은 바람직하게는 담배의 슈도모나스 시린개 pv. 타바시 매개 들불병이다.Second, the present invention relates to an inducer resistant to plant diseases, containing 4-carbamoylphenylacetic acid as an active ingredient. The plant disease is preferably Pseudomonas syringe pv. It is Tabashi mediated wildfire.
셋째, 본 발명은 식물체 뿌리에 4-카바모일페닐아세트산을 처리하는 단계를 포함하는, 식물병에 대한 저항성을 유도하는 방법에 관한 것이다. 상기 식물병은 바람직하게는 담배의 슈도모나스 시린개 pv. 타바시 매개 들불병이다.Third, the present invention relates to a method of inducing resistance to plant diseases, comprising treating 4-carbamoylphenylacetic acid on plant roots. The plant disease is preferably Pseudomonas syringe pv. It is Tabashi mediated wildfire.
본 발명은 식물병(예를 들어, 담배 들불병)에 대한 저항성을 유도하는 것으로 알려져 있었으나 그 기작 및 활성물질은 밝혀져 있지 않았던 슈도모나스 클로로라피스 O6 균주가 4-카바모일페닐아세트산을 생성함으로써 식물병에 대한 저항성을 유도하는 것을 최초로 규명한 것으로서, 4-카바모일페닐아세트산은 기존에 밝혀진 식물병 저항성 유도물질과 상이한 신규 물질이다. 본 발명을 이용하면, 식물(예를 들어, 담배)이 식물병(예를 들어, 슈도모나스 시린개 pv. 타바시 매개 들불병)에 대한 저항성을 갖게 함으로써 상기 식물병을 예방하는 효과를 나타내는 바, 기존에 밝혀진 식물병 저항성 유도물질과 더불어 식물병 예방 및 방제제로 효과적으로 사용될 수 있으며, 농작물 재배에 적용 시 농작물의 생산성을 높일 수 있다. 또한, 본 발명의 물질은 화학적으로 합성된 것이 아닌 생물학적으로 얻어진 것으로서, 친 환경 농업에서 식물병 방제 및 예방을 위해 적용될 수 있다.The present invention is known to induce resistance to plant diseases (eg, tobacco wildfire disease), but the mechanism and active substance of Pseudomonas chlororapis O6 strain, which is not known, produces 4-carbamoylphenylacetic acid in plant diseases. As the first to induce resistance to 4-carbamoylphenylacetic acid is a novel substance different from the known plant disease resistance inducer. Using the present invention, the plant (for example, tobacco) exhibits the effect of preventing the plant disease by making it resistant to plant diseases (for example, Pseudomonas syringe pv. In addition to the known plant disease resistance inducers can be effectively used as a plant disease prevention and control, and when applied to crop cultivation can increase the productivity of the crop. In addition, the material of the present invention is biologically obtained, not chemically synthesized, and may be applied for plant disease control and prevention in environmentally friendly agriculture.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명에서는, 식물병(예를 들어, 담배 들불병)에 대한 저항성을 유도하는 것으로 알려져 있었던 슈도모나스 클로로라피스 O6 균주가 생산하는 대사산물을 분리·동정하고, 이 물질이 실제로 식물병 저항성을 유도하는 활성을 갖는지를 검증하였다. 즉, 슈도모나스 클로로라피스 O6의 배양액을 여러 용매를 이용하여 추출 및 크로마토그래피 정제하고, 용매 및 크로마토그래피 정제 분획별 담배 들불병 저항성 유도활성을 시험하였다. 분리된 활성물질의 화학구조를 질량분석기와 핵자기공명분석기를 이용하여 분석하여 4-카바모일페닐아세트산으로 동정하고, 상기 물질이 실제로 들불병 저항성 유도활성을 갖는지를 생물학적으로 검증하였다.In the present invention, the metabolite produced by the Pseudomonas chlorolapis O6 strain known to induce resistance to plant diseases (eg, tobacco wildfire disease) is isolated and identified, and this substance actually induces plant disease resistance. The activity was verified. That is, the culture solution of Pseudomonas chlorolapis O6 was extracted and chromatographically purified using various solvents, and the tobacco wild-fire resistance resistance-inducing activity was tested for each fraction of solvent and chromatographic purification. The chemical structure of the isolated active material was analyzed using a mass spectrometer and a nuclear magnetic resonance analyzer to identify 4-carbamoylphenylacetic acid, and biologically verified that the material actually has wild-induced disease-inducing activity.
본 발명에서 담배 들불병 저항성 유도활성을 보이는 대사물질은 슈도모나스 클로로라피스 O6 균주의 배양액의 부탄올 추출물에 함유되어 있다. 상기 부탄올 추출물은 슈도모나스 클로로라피스 O6 균주의 배양액을 에틸아세테이트로 추출하여 수용액 층을 얻고, 이 수용액 층을 pH 2~4.5, 특히 pH 2 조건에서 부탄올로 추출하여 얻어질 수 있다. 상기 대사물질은 상기 추출물을 ODS 칼럼 크로마토그래피법으로 정제한 경우 40% 메탄올을 함유한 수용액 용출액에 함유되어 있다. 이로 인해 상기 추출물 및 용출액도 담배 들불병 저항성 유도활성을 나타낸다.In the present invention, the metabolite showing tobacco wild-blotting resistance inducing activity is contained in the butanol extract of the culture medium of Pseudomonas chlorolapis O6 strain. The butanol extract may be obtained by extracting a culture solution of Pseudomonas chlorolapis O6 strain with ethyl acetate to obtain an aqueous solution layer, and extracting the aqueous solution layer with butanol at
또한, 상기 대사물질은 상기 칼럼 크로마토그래피 정제 후 C-18 고상 칼럼이 부착되고 PDA 검출기가 장착된 고속액체크로마토그래피(HPLC)를 이용하여 파장 270 ㎚에서 트리플루오로아세트산이 첨가된 pH 2 조건의 20% 아세토니트릴 수용액 혼합 이동상으로 용리하여 분석하여 나타난 주요 크로마토그램을 대상으로 분획한 추출물에 함유되어 있다. 이로 인해 이 분획물도 담배 들불병 저항성 유도활성을 나타낸다.In addition, the metabolite was purified by the column chromatography, and the C-18 solid phase column was attached thereto, and then, using a high performance liquid chromatography (HPLC) equipped with a PDA detector, a
본 발명에서는, 상기의 반복적인 액체크로마토그래피 분석에서 얻어진 크로마토그램을 각각 분획하여 단일물질로 단리한 후, 단리된 물질별로 담배 들불병 저항성 유도활성 시험을 수행하였으며, 담배 들불병 저항성 유도활성을 보인 단리 물질을 질량분석기와 핵자기공명분석기를 통해 4-카바모일페닐아세트산으로 동정하였다.In the present invention, the chromatograms obtained from the above repeated liquid chromatography analysis were separated into single substances, and then the tobacco wild fire resistance resistance inducing activity test was performed for each isolated material, and the tobacco wild fire disease resistance inducing activity was shown. The isolated material was identified as 4-carbamoylphenylacetic acid by mass spectrometry and nuclear magnetic resonance analyzer.
본 발명에서는, 상기 물질이 실제로 담배 들불병 저항성을 유도하는지를 알아보기 위해 단리된 순수 물질을 담배의 뿌리에 처리한 다음 들불병균을 감염시킨 후 담배의 병징을 조사하였다. 또한, 기존에 담배 들불병에 대한 저항성을 유도하는 것으로 알려져 있는 참조 화합물(reference chemical)인 살리실산과 나노실리카를 비교 대상으로 선정하여 들불병 저항성 유도활성을 조사하였다.In the present invention, in order to determine whether the substance actually induces tobacco wildfire resistance, the isolated substance was treated at the root of the tobacco and then infected with the wild fire bacteria to investigate the symptoms of tobacco. In addition, the reference chemicals (salicylic acid and nanosilica), which are known to induce resistance to tobacco wild infestation, were selected as a comparison target and the wild-induced disease-inducing activity was investigated.
본 발명에 따른 4-카바모일페닐아세트산은 물에 용해하여 68 mM 수준으로 담배의 뿌리에 미리 처리한 후 들불병원균인 슈도모나스 시린개 pv. 타바시를 처리한 경우, 80% 이상의 들불병 발병 억제활성을 나타내는 것으로 확인되었다. 이러한 효과는 참조 화합물로 사용된 살리실산과 나노실리카와 유사한 수준의 효과이다. 따라서 본 발명의 4-카바모일페닐아세트산은 담배로 하여금 들불병에 대한 저항성을 갖게 하여 들불병을 예방하는 효과를 나타낼 수 있다. 4-카바모일페닐아세트산 은 물을 비롯한 수용성 용매에 용해하여 50~100 mM 수준으로 담배나 그의 서식지에 처리할 수 있으며, 바람직하게는 담배 뿌리에 관주하여 처리할 수 있다. 4-carbamoylphenylacetic acid according to the present invention is dissolved in water and treated in advance to the root of tobacco at 68 mM level, Pseudomonas syringae pv. In the case of treatment with Tabashi, it was confirmed that the activity of inhibiting the development of wildfire disease was 80% or more. This effect is similar to that of salicylic acid and nanosilica used as reference compounds. Therefore, 4-carbamoylphenylacetic acid of the present invention may have an effect of preventing wildfire disease by making tobacco resistant to wildfire disease. 4-carbamoylphenylacetic acid can be dissolved in water-soluble solvents, including water, and treated in tobacco or its habitat at a level of 50-100 mM, preferably by treatment with tobacco roots.
그밖에도, 슈도모나스 클로로라피스 O6 균주는 고추 세균성 시들음병균, 오이 갈반병균, 세균성 점무늬병균, 오이 모자이크 바이러스, 담배 무름병균, 묘시들음병균, 토양 곰팡이에 대한 전신 저항성과 가뭄에 대한 내성을 유도하는 활성을 갖는 바, 슈도모나스 클로로라피스 O6 균주로부터 유래된 4-카바모일페닐아세트산은 이러한 병원균에 대한 저항성을 유도하여 그에 의해 매개되는 식물병의 예방 및 방제와, 가뭄에 의한 작물 피해 경감에도 사용가능할 것이다.In addition, Pseudomonas Chlorophyll O6 strains have activity that induces systemic resistance to drought and bacterial resistance to drought, cucumber streptococcus, bacterial streaks, cucumber mosaic virus, tobacco purifying bacteria, mysterious fungi and soil fungi. As such, 4-carbamoylphenylacetic acid derived from Pseudomonas chlorolapis O6 strain may induce resistance to such pathogens and may be used for the prevention and control of plant diseases mediated by it and for the reduction of crop damage by drought.
이하, 본 발명을 실시예에 의해 보다 구체적으로 설명하나, 이는 본 발명의 이해를 돕기 위한 것일 뿐 본 발명의 범위를 어떤 식으로든지 제한하고자 하는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples, which are intended to aid the understanding of the present invention but are not intended to limit the scope of the present invention in any way.
실시예 1: 미생물의 배양, 및 배양액의 추출 및 정제Example 1: Cultivation of Microorganisms, and Extraction and Purification of Culture Solution
슈도모나스 클로로라피스 O6 균주(수탁번호 KACC 91054)를 루리아 브로스(LB) 및 항생제 암피실린과 스트렙토마이신이 각각 100 ㎎/ℓ가 포함된 액체 배지에서 27 ℃, 150 rpm에서 60 시간 배양하였다.Pseudomonas chlorolapis O6 strain (Accession No. KACC 91054) was incubated for 60 hours at 27 ° C. and 150 rpm in a liquid medium containing Luria Broth (LB) and antibiotics Ampicillin and
상기에서 얻은 슈도모나스 클로로라피스 O6 균주 배양액을 8000 rpm에서 15 분간 원심분리하였다. 원심분리 후 얻어진 상징액을 상징액의 두배 부피에 해당하는 에틸아세테이트로 용매추출을 실시하였다. 얻어진 수용액 층을 1 N 염산(HCl) 으로 pH를 2로 보정한 후 두배 부피에 해당하는 부탄올로 추출하였다. 부탄올 층을 수거하여 감압 농축한 후 30% 메탄올에 재용해하고, ODS 겔(와코실(Wakosil) C18, 일본) 칼럼크로마토그래피 방법을 이용하여 정제하였다. ODS 겔을 유리 칼럼(5 ㎝×50 cm, 가로×세로)에 메탄올로 슬러리 충진시킨 후, 물-메탄올 용매계를 이동상으로 하여 메탄올 비율을 10%씩 증가시키는 방법으로 용출 및 분획하였다. 40% 메탄올 용출분획에서 얻어진 분획을 다시 C-18 고상 칼럼과 PDA 검출기가 장착된 고속액체크로마토그래피(HPLC)를 통해 활성물질의 분리 및 분취를 실시하였다. 고속액체크로마토그래피의 분취 및 분석 조건은 다음과 같았다.Pseudomonas chlorophylla O6 strain culture obtained above was centrifuged for 15 minutes at 8000 rpm. The supernatant obtained after centrifugation was subjected to solvent extraction with ethyl acetate corresponding to twice the volume of the supernatant. The obtained aqueous solution layer was adjusted to 2 with 1 N hydrochloric acid (HCl), and then extracted with butanol corresponding to twice the volume. The butanol layer was collected, concentrated under reduced pressure, redissolved in 30% methanol, and purified using an ODS gel (Wakosil C18, Japan) column chromatography method. The ODS gel was slurry filled with methanol in a glass column (5 cm × 50 cm, horizontal × vertical), and then eluted and fractionated by increasing the methanol ratio by 10% with the water-methanol solvent system as the mobile phase. The fraction obtained from the 40% methanol elution fraction was separated and fractionated again by high performance liquid chromatography (HPLC) equipped with a C-18 solid column and a PDA detector. The preparative and analysis conditions of the high performance liquid chromatography were as follows.
① 기기모델: 디오넥스(Dionex) p680 HPLC① Instrument Model: Dionex p680 HPLC
② 검출기: PDA-100 포토다이오드 어레이 디텍터(Photodiode Array Detector)② Detector: PDA-100 Photodiode Array Detector
③ 분석파장: 270 nm③ Analysis wavelength: 270 nm
④ 분취칼럼: 워터스μ-본다팩™ 프렙 칼럼(Watersμ-Bondapak™ prep column)(C18 10 ㎛ 125 Å 19×300 mm)④ Preparative column: Watersμ - Bondapak ™ prep column (C18 10
⑤ 이동상: 트리플루오로아세트산이 함유된 pH 2 조건의 20% 아세토니트릴/물⑤ Mobile phase: 20% acetonitrile / water at
⑥ 이동상 유속: 4 ㎖/분⑥ mobile phase flow rate: 4 ml / min
그 결과를 도 1에 나타내었다. 도 1에 나타난 바와 같이, 고속액체크로마토그래피 분석을 통해 최종적으로 분리한 물질은 단일물질로 나타났다.The results are shown in FIG. As shown in FIG. 1, the finally separated material was identified as a single material through high performance liquid chromatography analysis.
실시예 2: 단리물질의 구조 결정Example 2 Structure Determination of Isolates
실시예 1에서 얻은 단일 물질의 화학구조를 고해상도 질량분석, 액체크로마토그래피 질량분석, 핵자기공명분석 방법을 통해 규명하였다.The chemical structure of the single material obtained in Example 1 was characterized by high resolution mass spectrometry, liquid chromatography mass spectrometry, and nuclear magnetic resonance analysis.
고해상도 질량분석 결과 분리한 물질의 분자량은 179.0602였으며, 분자식은 C7H10O2N2로 추정되었다. 액체크로마토그래피 질량분석 결과 (M+H)+값이 180이었으며 이는 163, 136, 119의 딸이온을 생성하였다. 딸이온의 질량분석 경향은 각각 m/z 163은 C2H7O3, m/z 136은 C7H6NO, m/z 119는 C8H7O2를 의미하였다(도 2).The molecular weight of the isolated material was 179.0602, and the molecular formula was estimated to be C 7 H 10 O 2 N 2 . The liquid chromatography mass spectrometry showed that the (M + H) + value was 180, which produced ions of 163, 136, and 119. The mass spectra of the daughter ions were m /
또한, 핵자기공명분석 결과를 아래 표 1에 나타내었다.In addition, the results of nuclear magnetic resonance analysis are shown in Table 1 below.
표 1에 나타낸 바와 같이, 1H-NMR(500 MHz, CD3OD)의 분석결과, δ2.15(s, 3H), δ7.65(d, 2H), δ7.95(d, 2H)에서 신호를 관찰하였다. 13C-NMR(500 MHz, CD3OD)을 통하여 7개의 탄소 신호를 관찰하였고, SP 3 탄소 1종(δ22.14), 카보닐 탄소 1종(δ172.11), 4차 탄소 2종(δ127.51, δ144.52), 올레핀 메틴 탄소 2종(δ120.18, δ 131.90)으로 구성된 화합물임을 확인하였다.As shown in Table 1, the analysis results of 1 H-NMR (500 MHz, CD 3 OD) showed that at δ2.15 (s, 3H), δ7.65 (d, 2H), and δ 7.95 (d, 2H). The signal was observed. Seven carbon signals were observed through 13 C-NMR (500 MHz, CD 3 OD), one SP 3 carbon (δ22.14), one carbonyl carbon (δ172.11), and two quaternary carbons ( It was confirmed that the compound was composed of δ 127.51, δ 144.52), and two kinds of olefin methine carbons (δ 120.18 and 131.90).
이상의 질량분석 및 핵자기공명분석 결과로부터 분리한 물질은 4-카바모일페닐아세트산으로 확인되었고(도 3), 이는 지금까지 보고되지 않는 신규 화합물이었다.The material isolated from the above mass spectrometry and nuclear magnetic resonance analysis was identified as 4-carbamoylphenylacetic acid (FIG. 3), which was a novel compound not reported so far.
실시예 3: 담배 들불병 저항성 유도활성의 생물학적 검증Example 3: Biological Verification of Tobacco Wild Disease Resistance Induction Activity
담배 종자를 70% 에탄올과 하이포아과염소산(HClO4)을 이용하여 표면 소독한 후, 비타민, 당 및 영양 물질이 포함된 배양 접시에서 3 일 동안 배양한 후 종자를 발아시켰다. 배양액 조성은 다음과 같다.Tobacco seeds were surface sterilized with 70% ethanol and hypochlorous acid (HClO 4 ), followed by incubation for 3 days in a culture dish containing vitamins, sugars, and nutrients, and the seeds were germinated. The culture composition is as follows.
비타민 함유 무라시게 & 스쿠그(Murashige & Skoog) 배지 4.4 g/ℓ4.4 g / l Murashige & Skoog medium with vitamin
2-모르폴리노에탄설폰산 일수화물 0.5 g/ℓ0.5 g / l 2-morpholinoethanesulfonic acid monohydrate
슈크로스 30 g/ℓSucrose 30 g / ℓ
파이토젤 아가 5 g/ℓPhytogel Agar 5 g / L
발아된 종자를 조직 배양접시로 옮겨 심은 후, 명조건과 암조건이 각각 14 시간 및 10 시간 되는 장소에서 담배를 배양하였다. 약 2 주일 후 담배 잎이 5~6개까지 생장하였을 때 실시예 2에서 분리된 들불병 저항성 유도물질, 4-카바모일페닐아세트산을 물에 용해한 다음 68 mM 수준으로 담배 뿌리에 관주처리하였다. 처리 5일 후 담배 들불병원균 슈도모나스 시린개 pv. 타바시를 1.0×108 세포 수준으로 담배 잎에 처리하였다. 병원균 처리 3 일 후 담배 잎에서 관찰되는 들불병 발병을 조사하였다. 대조구에는 증류수를 처리하였으며, 참조구에는 1 mM 농도의 살리실산과 80 mM의 나노실리카를 처리하였다.The germinated seeds were transferred to a tissue culture dish and planted, and then tobacco was incubated at a place where light and dark conditions were 14 and 10 hours, respectively. After about two weeks, when up to 5-6 tobacco leaves were grown, the wild ill-resistant inducer, 4-carbamoylphenylacetic acid, isolated in Example 2 was dissolved in water and irrigated to tobacco roots at 68 mM level. After 5 days of treatment, the tobacco wildfire pathogen Pseudomonas syringe pv. Tabashi was treated on tobacco leaves at the level of 1.0 × 10 8 cells. The incidence of wildfire disease observed in tobacco leaves after 3 days of pathogen treatment was investigated. The control group was treated with distilled water, and the reference group was treated with 1 mM salicylic acid and 80 mM nanosilica.
그 결과를 도 4에 나타내었다. 도 4에 나타낸 바와 같이, 본 발명의 4-카바모일페닐아세트산은 대조구에 비해 약 80% 수준의 담배 들불병 발병 억제효과를 나타내었다. 이는 참조화합물인 실리실산과 나노실리카의 발병 억제효과와 유사한 수준이었다. 즉, 단일물질을 분리하기 전 슈도모나스 클로로라피스 O6 배양원액을 처리한 경우에도 들불병 발병율은 대조구에 비해 현저하게 억제되었으며, 이 배양액으로부터 순수 분리된 4-카바모일페닐아세트산처리 시에도 현저한 들불병 발병 억제효과를 나타내었다. 이는 참조화합물 처리 시와 유사한 효과였다.The results are shown in FIG. As shown in Figure 4, 4-carbamoylphenylacetic acid of the present invention showed about 80% level of tobacco wild fire disease inhibition effect compared to the control. This was similar to the effect of inhibiting the onset of the reference compounds, silicic acid and nanosilica. In other words, even when the Pseudomonas chloro-lapis O6 culture stock was treated before the separation of a single substance, the incidence of wildfire disease was remarkably suppressed compared to the control group. Inhibitory effect was shown. This was a similar effect as the treatment of the reference compound.
상기 결과는 본 발명의 4-카바모일페닐아세트산이 담배에서 슈도모나스 클로로라피스 O6가 식물병 저항성 유도활성을 나타내게 하는 주요 대사물질임을 의미하는 것이다.The results indicate that 4-carbamoylphenylacetic acid of the present invention is a major metabolite that causes Pseudomonas chlorolapis O6 to exhibit plant disease resistance inducing activity in tobacco.
도 1은 슈도모나스 클로로라피스 O6 균주 배양액에서 분리한 식물병 저항성 유도물질 4-카바모일페닐아세트산의 액체크로마토그래피 분석 결과를 보여주는 도면이고;BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 shows the results of liquid chromatography analysis of plant disease resistance inducer 4-carbamoylphenylacetic acid isolated from Pseudomonas chlorolapis O6 strain culture medium;
도 2는 슈도모나스 클로로라피스 O6 균주 배양액에서 분리한 식물병 저항성 유도물질 4- 카바모일페닐아세트산의 액체크로마토그래피 질량분석 결과를 보여주는 도면이며;FIG. 2 is a diagram showing the results of liquid chromatography mass spectrometry of plant disease resistance inducer 4-carbamoylphenylacetic acid isolated from Pseudomonas chlorolapis O6 strain culture medium; FIG.
도 3은 슈도모나스 클로로라피스 O6 균주 배양액에서 분리한 식물병 저항성 유도물질 4- 카바모일페닐아세트산의 화학구조를 보여주는 도면이며;Figure 3 is a view showing the chemical structure of the plant disease resistance inducer 4-carbamoylphenylacetic acid isolated from Pseudomonas Chlorophyll O6 strain culture medium;
도 4는 생물학적 검정 실험에서 식물병 저항성 유도물질 4- 카바모일페닐아세트산의 식물병 발병 억제효과를 나타낸 그래프이고;Figure 4 is a graph showing the plant disease resistance inhibitory effect of plant disease resistance inducer 4-carbamoylphenylacetic acid in the biological assay experiment;
도 5는 식물병 저항성 유도물질 4- 카바모일페닐아세트산을 처리한 후 담배의 식물병원균 감염 정도를 보여주는 사진이다.Figure 5 is a photograph showing the degree of infection of phytopathogens of tobacco after treatment with plant disease resistance inducer 4-carbamoylphenylacetic acid.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070093239A KR100891720B1 (en) | 2007-09-13 | 2007-09-13 | 4-carbamoylphenylacetic acid from Pseudomonas chlororapis O6 which induces resistance to plant diseases and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070093239A KR100891720B1 (en) | 2007-09-13 | 2007-09-13 | 4-carbamoylphenylacetic acid from Pseudomonas chlororapis O6 which induces resistance to plant diseases and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100891720B1 true KR100891720B1 (en) | 2009-04-03 |
Family
ID=40757237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070093239A Expired - Fee Related KR100891720B1 (en) | 2007-09-13 | 2007-09-13 | 4-carbamoylphenylacetic acid from Pseudomonas chlororapis O6 which induces resistance to plant diseases and uses thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100891720B1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1082943A (en) * | 1963-03-27 | 1967-09-13 | Glaxo Lab Ltd | Derivatives of 7-aminocephalosporanic acid |
KR100358671B1 (en) | 1994-04-18 | 2003-04-26 | 스벤스카 란트멘넨, 릭스푀르분트 에크. 푀르. | Plant Disease Control Compositions and Methods |
KR100521744B1 (en) | 2003-09-08 | 2005-10-17 | 전남대학교산학협력단 | Pseudomonas chlororaphis O6 and Plant Diseases Control and Drought Damage Reduction Method using The Same |
-
2007
- 2007-09-13 KR KR1020070093239A patent/KR100891720B1/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1082943A (en) * | 1963-03-27 | 1967-09-13 | Glaxo Lab Ltd | Derivatives of 7-aminocephalosporanic acid |
KR100358671B1 (en) | 1994-04-18 | 2003-04-26 | 스벤스카 란트멘넨, 릭스푀르분트 에크. 푀르. | Plant Disease Control Compositions and Methods |
KR100521744B1 (en) | 2003-09-08 | 2005-10-17 | 전남대학교산학협력단 | Pseudomonas chlororaphis O6 and Plant Diseases Control and Drought Damage Reduction Method using The Same |
Non-Patent Citations (1)
Title |
---|
PMPP, 2003 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | The composition of root exudates from two different resistant peanut cultivars and their effects on the growth of soil-borne pathogen | |
Lavania et al. | Induction of plant defense enzymes and phenolics by treatment with plant growth–promoting rhizobacteria Serratia marcescens NBRI1213 | |
Mukherjee et al. | Ferricrocin, the intracellular siderophore of Trichoderma virens, is involved in growth, conidiation, gliotoxin biosynthesis and induction of systemic resistance in maize | |
Chen et al. | Role of salicylic acid in systemic resistance induced by Pseudomonas spp. against Pythium aphanidermatum in cucumber roots | |
Coquoz et al. | Arachidonic acid induces local but not systemic synthesis of salicylic acid and confers systemic resistance in potato plants to Phytophthora infestans and Alternaria solani | |
Cartwright et al. | Phytoalexin production in rice and its enhancement by a dichlorocyclopropane fungicide | |
Tanaka et al. | Phenylpropanoid amides of serotonin accumulate in witches’ broom diseased bamboo | |
Teresa et al. | The avocado defense compound phenol-2, 4-bis (1, 1-dimethylethyl) is induced by arachidonic acid and acts via the inhibition of hydrogen peroxide production by pathogens | |
Queiroz et al. | Bioassay-directed isolation and identification of phytotoxic and fungitoxic acetylenes from Conyza canadensis | |
Yuan et al. | Isolation of methyl gallate from Toxicodendron sylvestre and its effect on tomato bacterial wilt | |
Hoss et al. | Function of host and fungal metabolites in resistance response of banana and plantain in the black Sigatoka disease pathosystem (Musa spp.–Mycosphaerella fijiensis) | |
Fyans et al. | Isolation and characterization of plant-pathogenic Streptomyces species associated with common scab-infected potato tubers in Newfoundland | |
Lerat et al. | Streptomyces scabiei and its toxin thaxtomin A induce scopoletin biosynthesis in tobacco and Arabidopsis thaliana | |
WO2007012184A1 (en) | Fungal isolates and biological control compositions for the control of weeds | |
Tietjen et al. | Phytotoxins from Alternaria carthami Chowdhury: Structural identification and physiological significance | |
Bahraminejad et al. | Evaluation of inhibitory effects of extracts of plants from western Iran against'Phytophthora'drechsleri | |
EP1154692B1 (en) | A method of controlling fungal pathogens, and agents useful for same | |
Ivanov et al. | The chemoattractant potential of ginsenosides in the ginseng–Pythium irregulare pathosystem | |
Yang et al. | Degraded Metabolites of Phlorizin Promote Germination of Valsa mali var. mali in its Host Malus spp. | |
Balah | Weed control ability of egyptian natural products against annual, perennial and parasitic weeds | |
Dor et al. | The influence of growth conditions on biomass, toxins and pathogenicity of Fusarium oxysporum f. sp. orthoceras, a potential agent for broomrape biocontrol | |
KR20220066845A (en) | Composition for controlling plant disease comprising culture solution of Streptomyces sp. Strain or extract thereof, and controlling method for plant disease | |
Parada et al. | Destruxin B produced by Alternaria brassicae does not induce accessibility of host plants to fungal invasion | |
Muto et al. | Toxicity of black nightshade (Solanum nigrum) extracts on Alternaria brassicicola, causal agent of black leaf spot of Chinese cabbage (Brassica pekinensis) | |
Yoshida et al. | Colletotrichum dematium produces phytotoxins in anthracnose lesions of mulberry leaves |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20070913 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20080624 Patent event code: PE09021S01D |
|
AMND | Amendment | ||
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20081103 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20080624 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
PJ0201 | Trial against decision of rejection |
Patent event date: 20081107 Comment text: Request for Trial against Decision on Refusal Patent event code: PJ02012R01D Patent event date: 20081103 Comment text: Decision to Refuse Application Patent event code: PJ02011S01I Appeal kind category: Appeal against decision to decline refusal Decision date: 20090102 Appeal identifier: 2008101011758 Request date: 20081107 |
|
PB0901 | Examination by re-examination before a trial |
Comment text: Amendment to Specification, etc. Patent event date: 20081107 Patent event code: PB09011R02I Comment text: Request for Trial against Decision on Refusal Patent event date: 20081107 Patent event code: PB09011R01I Comment text: Amendment to Specification, etc. Patent event date: 20080728 Patent event code: PB09011R02I |
|
B701 | Decision to grant | ||
PB0701 | Decision of registration after re-examination before a trial |
Patent event date: 20090102 Comment text: Decision to Grant Registration Patent event code: PB07012S01D Patent event date: 20081209 Comment text: Transfer of Trial File for Re-examination before a Trial Patent event code: PB07011S01I |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20090327 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20090330 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20120328 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20130201 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20130201 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140203 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20140203 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20150130 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20150130 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20160316 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20160316 Start annual number: 8 End annual number: 8 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20180107 |